AI in Brief — Wednesday, 18 November 2026
Isomorphic Labs, the AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round as it prepares to advance drug candidates into clinical trials. The capital injection underscores growing investor confidence in AI-driven pharmaceutical development, with Isomorphic now positioned to move beyond computational drug discovery into
AI in Brief — Wednesday, 18 November 2026 Read More »
